Safety and efficacy of eribulin plus trastuzumab in pretreated HER2-positive advanced breast cancer (ABC) patients. An Italian multicenter experienceE.S. Lutrino, Saverio Cinieri, Giovanna Giordano et al.|Annals of Oncology|2016Cited by 1